SCREEN Semiconductor Solutions and IBM Research to Collaborate on Advanced Logic Process Research in Albany, New York
SCREEN Semiconductor Solutions Co., Ltd. (SCREEN) is preparing to install our first of three key tool sets into the IBM Research (IBM) Albany Nanotech, Semiconductor Research Center this year. The SCREEN single wafer clean, laser anneal and coat/develop track equipment suite will support IBM’s advanced semiconductor technology research, and complements the EUV Center of Excellence tool set in Albany, New York.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161011005040/en/
“IBM is committed to an aggressive research agenda that pushes the limits of semiconductor technology,” said Mukesh Khare, vice president of IBM Research’s Semiconductor Group. “Innovations in materials, processes and device structures are essential to accelerate technology research in order to meet the demands of future cloud computing and cognitive systems.”
“We are very pleased to be chosen by IBM as they research advanced logic semiconductors,” noted Tadahiro Suhara, President of SCREEN Semiconductor Solutions, “For us this is a testament to the value our SCREEN equipment technology and resources bring to advance semiconductor process development in multiple fields: wet clean, thermal anneal, and coat/develop track.”
The first of the SCREEN equipment trio installation for IBM will be the Aquaspin SU-3200 which was designed to develop highly selective, residue free and damage free wet clean process applications in semiconductor fabrication for advanced nodes including 7nm and beyond. IBM will also evaluate nanosecond-scale UV laser anneal applications, including melt activation and re-crystallization of critical layers, with the LT-3100 system delivery from Laser Systems and Solutions of Europe (LASSE), SCREEN’s subsidiary based in France. We anticipate upon favorable results that IBM will integrate the DT-3000 DUO Track system to advance Directed Self-Assembly (DSA), Spin-On Dielectrics (SOD) and under layer coatings with the EUV Center of Excellence lithography patterning tool set.
These three new SCREEN tool sets are expected to be delivered before yearend to the IBM Research, Albany Nanotech site cleanrooms within the SUNY Polytechnic Institute’s Colleges of Nanoscale Science and Engineering (CNSE). This 300 mm wafer size equipment set for IBM will expand SCREEN’s presence in Albany.
About IBM Research
For more than seven decades, IBM Research has defined the future of
information technology with more than 3,000 researchers in 13 labs
located across six continents. Scientists from IBM Research have
produced six Nobel Laureates, 10 U.S. National Medals of Technology,
five U.S. National Medals of Science, six Turing Awards, 19 inductees in
the National Academy of Sciences and 19 inductees into the U.S. National
Inventors Hall of Fame.
For more information about IBM Research, visit www.ibm.com/research.
About SCREEN Semiconductor Solutions Co., Ltd.
SCREEN Semiconductor Solutions has been established as a group company
of SCREEN Holdings inheriting the semiconductor equipment business from
its predecessor, Dainippon Screen. SCREEN is a specialized manufacturer
in various areas such as wafer cleaning equipment, lithography equipment
and thermal anneals, and is one of the world’s top 10 equipment
suppliers to the semiconductor manufacturing industry.
For more information, please visit www.screen.co.jp/eng/spe.
SCREEN Semiconductor Solutions Co., Ltd.
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Murex to Offer MX.3 Risk, Trading and Post-Trade Solutions on the AWS Cloud12.12.2017 14:00 | Pressemelding
Murex, an industry leader in trading, risk management and processing solutions for capital markets, announced they will run their MX.3 technology platform on Amazon Web Services, Inc. (AWS). With the acceleration of cloud adoption in capital markets, Murex and AWS agreed to collaborate to help clients migrate their Murex application workloads to the AWS Cloud. Murex clients are looking to consolidate more and more of their capital markets activity on the MX.3 platform and this means their need for infrastructure is increasing. New regulatory requirements are also driving financial organizations to use cloud to scale up their computing capacity. Murex is collaborating with AWS to meet the demand from clients to support deployment of the Murex offering on the AWS Cloud. Murex is working on the validation of a range of deployment scenarios, from using AWS Cloud for bursting grid
Darzalex®▼(daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible12.12.2017 13:33 | Pressemelding
Janssen-Cilag International NV (“Janssen”) today announced data from the Phase 3 ALCYONE study, showing Darzalex® (daratumumab) in combination with bortezomib, melphalan and prednisone (VMP) significantly improved clinical outcomes, including reducing the risk of disease progression or death by 50 percent, in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation (ASCT).1 These data were accepted as a late-breaking abstract (LBA) for presentation at the 59th American Society of Hematology (ASH) Annual Meeting in Atlanta, today at 7:30 a.m. ET (Abstract #LBA-4).1 Study findings were simultaneously published in the New England Journal of Medicine (NEJM) . 2 Daratumumab is currently indicated for use in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for
CTS Engines Announces Senior Management Hire12.12.2017 13:00 | Pressemelding
CTS Engines, the global leader for mature jet engine maintenance, announced today that it had hired Diane E. Cavuoto as Senior Vice President, Supply Chain, in an effort to continue to provide its customers with outstanding engine overhaul services. Ms. Cavuoto will be based in CTS’s Ft. Lauderdale headquarters and will report directly to Vesa Paukkeri, CTS’s President and Chief Operating Officer. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005050/en/ Diane E. Cavuoto, Senior Vice President, Supply Chain, for CTS Engines (Photo: Business Wire) Ms. Cavuoto, most recently Vice President, Strategic Sourcing at Honeywell International, brings years of supply chain management experience to CTS. In her prior role at Honeywell, Ms. Cavuoto managed a global commodity team of 150 employees managing $4
MIPI Alliance Opens Access to its MIPI I3C Sensor Interface Specification12.12.2017 13:00 | Pressemelding
The MIPI® Alliance, an international organization that develops interface specifications for mobile and mobile-influenced industries, today announced it is opening access to its sensor interface specification, MIPI I3C. Starting today, all companies, including those not currently members of MIPI Alliance, may access the MIPI I3C v1.0 specification so they may evaluate the incorporation of the specification into their sensor integration plans and design applications. “MIPI I3C provides a welcome update to the I2C technology that has been widely adopted over the past 35 years. Extending access provides an opportunity to spur innovation and help other industries beyond mobile," said Joel Huloux, chairman of MIPI Alliance. "It helps MIPI members as well, because it supports greater adoption and interoperability, strengthens the ecosystem and provides for a richer
ADC Therapeutics Announces Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-30112.12.2017 11:23 | Pressemelding
ADC Therapeutics (ADCT), an oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers, today announced clinical data from two ongoing Phase I clinical trials evaluating ADCT-301 (camidanlumab tesirine or “Cami-T”) in important subtypes of lymphoma and leukemia. The data were presented at the 59th American Society of Hematology (ASH) Annual Meeting in Atlanta, USA. 1. Interim results of a Phase I open label, single agent, dose-escalating study of ADCT-301 evaluating tolerability, safety, pharmacokinetics and efficacy in patients with relapsed or refractory B-cell Hodgkin’s or non-Hodgkin’s lymphoma Dr. Steven M. Horwitz, Medical Oncologist at Memorial Sloan Kettering Cancer Center in New York City, and Principal Investigator, s
LTI to Offer Blockchain Solution Powered by Microsoft Azure12.12.2017 10:45 | Pressemelding
Larsen & Toubro Infotech Ltd. (NSE: LTI, BSE: 540005), a global technology consulting and digital solutions company, announced today the availability of its blockchain-based trade finance solution on Microsoft Azure marketplace. The solution tracks the flow of goods in a value chain, improving transparency across multiple entities involved. It enables accelerated adoption of distributed ledger technologies by bringing together LTI’s deep industry knowledge and blockchain capabilities together with Microsoft’s expertise in cloud-based solutions. Aftab Ullah, Chief Operating Officer, LTI said, "Our vision is to deliver exponential operational efficiencies to the world’s leading companies through digital innovation. LTI’s Blockchain services include end-to-end consulting and implementation and are designed to help transform our clients’ business operations. The collaboration
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom